# The Lancet

Type: Product

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/the-lancet-product
Canonical HTML page: https://gethealthbrief.com/entity/the-lancet-product

## Timeline

- **2026-06-12**: Lancet Series on Postpartum Haemorrhage Published — The Lancet releases a three-part series consolidating evidence on PPH, the E-MOTIVE strategy, and implementation guidance, with a special emphasis on high-burden countries like India.
- **2026-03-17T00:59:18Z**: Mental Health Focus — Cannabis clinics see a surge in patients seeking treatment for anxiety and PTSD.
- **2026-03-17T00:59:18Z**: Clinical Findings Released — The Lancet publishes data showing no significant benefit over placebo for psychiatric conditions.
- **2023**: E-MOTIVE Trial Published — A large cluster-randomized trial across low- and middle-income countries demonstrates that objective blood-loss measurement with a calibrated drape plus a bundled treatment package significantly reduces PPH-related severe morbidity and mortality.
- **2016-02-24**: Legalization Milestone — Australia legalizes medicinal cannabis at the federal level, sparking industry growth.

## Recent coverage (2 stories)

### Simple Drape Bundle Could Cut 38% of Maternal PPH Deaths: Lancet Series
2026-06-30 00:29:00 · Sentiment: Strongly positive · Impact: 8/10 · Sources: 2

The Lancet series validates the E-MOTIVE bundle as a low-cost, scalable fix for postpartum hemorrhage, which accounts for up to 38% of maternal deaths in India. For healthcare providers, the drape-based early detection and standardized treatment protocol promise to overhaul emergency obstetric workflows and save thousands of lives.
Full story: https://gethealthbrief.com/story/simple-drape-bundle-cut-pph-deaths-lancet

### Lancet Study Finds Medicinal Cannabis Ineffective for Mental Health Conditions
2026-03-17 00:59:18 · Sentiment: Negative · Impact: 7/10 · Sources: 2

A landmark study published in The Lancet has concluded that medicinal cannabis is no more effective than a placebo in treating anxiety, depression, and PTSD. The findings challenge the multi-billion dollar cannabis industry's reliance on mental health prescriptions and could trigger significant regulatory shifts.
Full story: https://gethealthbrief.com/story/lancet-study-medicinal-cannabis-ineffective-mental-health

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.